Research Projects & Grants

Federal

  • Evaluation of intravenous gamma globulin as an agent to lower allosensitization and improve allograft survival in highly-sensitized adult ESRD patients, Role: Investigator, National Institutes of Health/DHHS, (09/2002 - 09/2003) Status: Completed

For Profit Organization

  • A three-month open-label, two-cohort study to investigate the safety and tolerability of myfortic in combination with neoral and tacrolimus in renal transplant recipients with GI intolerance, Role: Investigator, Novartis Pharmaceuticals Corporation, (11/2005 - 11/2006) Status: Completed
  • Registry of Simulect (basiliximab) use in living donor renal transplants (ReSULTs)., Role: Investigator, Novartis Pharma AG, (07/2005 - 07/2006) Status: Completed
  • A one-year, multicenter, partially blinded, double-dummy, randomized study to evaluate the efficacy and safety of FTY720 combined with reduced-dose or full-dose Neoral and corticosteroids versus mycophenolate mofetil (MMF, CellCept) combined with full-dose Neoral and corticosteroids, in de novo adult renal transplant recipients, Role: Investigator, Novartis Pharmaceuticals Corporation, (06/2004 - 10/2004) Status: Completed
  • An open-label, multicenter study to further characterize the clinical utility and safety of rapamune and cyclosporine combination treatment in de novo renal allograft recipients (Project #0468E1, dated 01/12/99)., Role: Investigator, Wyeth-Ayerst Laboratories, (04/2000 - 04/2001) Status: Completed
  • A randomized, multicenter, comparative trial of prograf (Tacrolimus) in combination with rapamune (Sirolimus) or cellcept (Mycophenolate Mofetil) after kidney transplant, Role: PI, Fujisawa, Status: Completed
  • A randomized comparative trial of the effects of antilymphocyte induction on the tacrolimus plus mycophenolate mofetil maintenance immunosuppression after simultaneous kidney/pancreas transplantation, Role: PI, Fujisawa, Status: Completed
  • Rescue immunosuppressant therapy for kidney, Role: PI, Wyeth-Ayerst Laboratories, Status: Completed

Internal

  • Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab, Role: Investigator, LLU Dept. of Surgery, (01/2006 - 01/2007) Status: Completed
  • A restrospective study evaluating cytomegalovirus prophylaxis in kidney and liver transplant recipients., Role: Investigator, LLU Transplantation Institute, (08/2004) Status: Completed
  • Use of Basiliximab with Mycophenolate Mofetil in kidney transplantation, Role: Investigator, LLU Transplantation Institute, (04/2003) Status: Completed
  • Antibody induction therapy in combination with mycophenolate mofetil in pediatric kidney transplantation, Role: Investigator, LLU Transplantation Institute, (04/2003) Status: Completed